Latest Regulatory Changes News

Page 1 of 32
The a2 Milk Company says China-label infant formula offtake has recovered to about half of pre-disruption levels, but expects total IMF sales to remain broadly flat in FY27. Group revenue and EBITDA are still forecast to grow, with earnings heavily weighted to the second half.
Victor Sage
Victor Sage
19 Nov 2026
Smart Parking has posted record FY26 revenue of $126.0 million and adjusted EBITDA of $30.8 million, while setting a target of 3,000 ANPR sites by December 2028. The next phase will require the company to turn US investment, acquisitions and regulatory progress into sustained site growth.
Victor Sage
Victor Sage
13 Nov 2026
Macquarie Group delivered a 50% rise in first-half profit to A$2.478 billion, with Commodities and Global Markets providing the standout contribution as market activity accelerated. The result also marks Shemara Wikramanayake’s final day as chief executive, with Greg Ward taking over from 7 November.
Claire Turing
Claire Turing
6 Nov 2026
Regions Financial expects fourth-quarter net interest income to rise 1% to 2% sequentially, while third-quarter adjusted earnings reached US$622 million. The bank also reported improving non-performing loans and net charge-offs, but flagged interest-rate and commercial credit risks that remain central to its outlook.
Victor Sage
Victor Sage
5 Nov 2026
Novatti’s AU/NZ quarterly transaction value rose to $1.2 billion, but regulatory disruption to international BPAY payments pushed revenue lower and left Cash EBITDA negative. The company is targeting an early 2027 relaunch while relying on pipeline conversion and product mix improvements to support its next phase of growth.
Claire Turing
Claire Turing
30 Oct 2026
PeopleIN improved underlying earnings and reduced leverage in FY26 despite a statutory loss, as Queensland’s infrastructure demand drove a sharp recovery in its core workforce division. The company is now betting that a leaner portfolio, Infrawork’s trans-Tasman labour channel and Brisbane 2032-related work can sustain the upturn.
Victor Sage
Victor Sage
23 Oct 2026
Aeris Resources finished FY26 with $178.5 million in net profit, $290.2 million of EBITDA and no material debt, while Tritton’s copper reserves expanded sharply. The challenge now shifts from rebuilding the balance sheet to converting a larger resource base into sustained production.
Maxwell Dee
Maxwell Dee
16 Oct 2026
Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.
Victor Sage
Victor Sage
14 Oct 2026
EDU Holdings has lifted total enrolments 26% to a record 7,489, with Higher Education up 45% and now accounting for 88% of the group. The result also exposes a sharper divide: domestic and postgraduate demand is strengthening, while international VET enrolments continue to contract.
Victor Sage
Victor Sage
13 Oct 2026
Cokal’s 60%-owned BBM subsidiary has pushed repayment of a US$20 million capital sum from January 2027 to January 2030. The relief comes with deferred fees carrying 10% annual interest and marketing rights over the first 20 million tonnes of mine production.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.
Ada Torres
Ada Torres
24 Sept 2026
Cauldron Energy has extended uranium mineralisation strike lengths by approximately 2.5 kilometres at both Manyingee South and Manyingee North within its Yanrey Uranium Project, underpinning significant resource growth potential.
Maxwell Dee
Maxwell Dee
2 Sept 2026

Browse the archive

Full archive